|
|
Article: Increasing Adoption of Computational Biology Tools in Drug Discovery Industry.
- Article from:
- PR Newswire Europe
- Article date:
- August 29, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
LONDON, August 29 /PRNewswire/ -- In a move aimed at augmenting shrinking product pipelines, the drug discovery industry is employing high-level computational biology tools. The industry also expects to reduce the duration of the drug discovery process, especially in toxicology and drug efficacy studies.
New analysis from Frost & Sullivan (www.biotech.frost.com), World Computational Biology Markets, reveals that revenues in these markets totalled USD 60.0 million in 2004 and can reach USD 751.8 million in 2011.
An increase in royalty and milestone payment agreements is strengthening strategic partnerships between computational biology tools vendors ...